These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 27419905

  • 1. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.
    Teramoto T, Uno K, Miyoshi I, Khan I, Gorcyca K, Sanchez RJ, Yoshida S, Mawatari K, Masaki T, Arai H, Yamashita S.
    Atherosclerosis; 2016 Aug; 251():248-254. PubMed ID: 27419905
    [Abstract] [Full Text] [Related]

  • 2. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W, Dippel FW, Theobald K, Gorcyca K, Iorga ŞR, Ansell D.
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [Abstract] [Full Text] [Related]

  • 3. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M, Ansell D, Averna M, Fanelli F, Gorcyca K, Iorga ŞR, Maggioni AP, Paizis G, Tomic R, Catapano AL.
    Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
    [Abstract] [Full Text] [Related]

  • 4. Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands.
    Kuiper JG, Sanchez RJ, Houben E, Heintjes EM, Penning-van Beest FJA, Khan I, van Riemsdijk M, Herings RMC.
    Clin Ther; 2017 Apr; 39(4):819-827.e1. PubMed ID: 28347514
    [Abstract] [Full Text] [Related]

  • 5. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
    Wang X, He Y, Wang T, Li C, Ma Z, Zhang H, Ma H, Zhao H.
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
    [Abstract] [Full Text] [Related]

  • 6. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ, Watson KE, Talbert RL.
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [Abstract] [Full Text] [Related]

  • 7. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL, Khan I, Ansell D, Sanchez RJ, Ray KK.
    BMJ Open; 2017 Feb 17; 7(2):e013255. PubMed ID: 28213597
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP, Foody JM, Tomassini JE, Sajjan SG, Ramey DR, Neff DR, Tershakovec AM, Hu XH, Tunceli K.
    J Clin Lipidol; 2014 Feb 17; 8(1):107-16. PubMed ID: 24528691
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
    Fox KM, Tai MH, Kostev K, Hatz M, Qian Y, Laufs U.
    Clin Res Cardiol; 2018 May 17; 107(5):380-388. PubMed ID: 29273856
    [Abstract] [Full Text] [Related]

  • 11. Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database.
    Jameson K, Zhang Q, Zhao C, Ramey DR, Tershakovec AM, Gutkin SW, Marrett E.
    Curr Med Res Opin; 2014 Apr 17; 30(4):655-65. PubMed ID: 24495126
    [Abstract] [Full Text] [Related]

  • 12. Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.
    Ambegaonkar BM, Bash LD, Chirovsky DR, Jameson K, Grant S, Nocea G, Pettersson B, Sazonov V.
    Eur J Intern Med; 2013 Oct 17; 24(7):656-63. PubMed ID: 23953848
    [Abstract] [Full Text] [Related]

  • 13. Patterns of statin use and cholesterol goal attainment in a high-risk cardiovascular population: A retrospective study of primary care electronic medical records.
    García-Gil M, Blanch J, Comas-Cufí M, Daunis-i-Estadella J, Bolíbar B, Martí R, Ponjoan A, Alves-Cabratosa L, Ramos R.
    J Clin Lipidol; 2016 Oct 17; 10(1):134-42. PubMed ID: 26892130
    [Abstract] [Full Text] [Related]

  • 14. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT, Poh KK, Brudi P, Ambegaonkar B.
    Atherosclerosis; 2017 Nov 17; 266():158-166. PubMed ID: 29028484
    [Abstract] [Full Text] [Related]

  • 15. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ, Marín Ibáñez A, Pérez-Jiménez F, Pintó X, Nocea G, Ahumada C, Alemao E, Yin D, REALITY Study Group.
    Pharmacoeconomics; 2004 Nov 17; 22 Suppl 3():1-12. PubMed ID: 15669149
    [Abstract] [Full Text] [Related]

  • 16. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
    Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C.
    J Manag Care Pharm; 2007 Oct 17; 13(8):652-63. PubMed ID: 17970603
    [Abstract] [Full Text] [Related]

  • 17. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
    Ambegaonkar B, Chirovsky D, Tse HF, Lau YK, Tomlinson B, Li SK, Yue CS, Wong TH, Choi MC, Tunggal P, Sazonov V.
    Adv Ther; 2012 May 17; 29(5):427-41. PubMed ID: 22562782
    [Abstract] [Full Text] [Related]

  • 18. Lipid attainment among patients newly treated with lipid-altering drugs.
    Hess G, Chang CL, Chung K.
    Curr Med Res Opin; 2014 Sep 17; 30(9):1743-56. PubMed ID: 24889282
    [Abstract] [Full Text] [Related]

  • 19. Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study.
    Yang YS, Yang BR, Kim MS, Hwang Y, Choi SH.
    Lipids Health Dis; 2020 Jan 11; 19(1):5. PubMed ID: 31926562
    [Abstract] [Full Text] [Related]

  • 20. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
    Chan RH, Chan PH, Chan KK, Lam SC, Hai JJ, Wong MK, Tam FC, Lam L, Chan CW, Lam YM, Siu DC, Tse HF, Lee SW.
    Hong Kong Med J; 2012 Oct 11; 18(5):395-406. PubMed ID: 23018067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.